Trial
NCT00424489
Hematopoietic Stem Cell Therapy for Patients With Refractory Myasthenia Gravis
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Northwestern University
Collaborators
—
Condition
Myasthenia Gravis
Intervention
Hematopoietic Stem Cell Transplantation
Why stopped
No participants enrolled for more than two years. No plan to continue study.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-08-31